Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011–2013()

BACKGROUND: In May 2011, the first trivalent inactivated influenza vaccine exclusively for intradermal administration (TIV-ID) was licensed in the US for adults aged 18–64 years. OBJECTIVE: To characterize adverse events (AEs) after TIV-ID reported to the US Vaccine Adverse Event Reporting System (V...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Vaccine
Auteurs principaux: Moro, Pedro L., Harrington, Theresa, Shimabukuro, Tom, Cano, Maria, Museru, Oidda I., Menschik, David, Broder, Karen
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771265/
https://ncbi.nlm.nih.gov/pubmed/23994022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.08.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires